argenx SE (ARGX) Financials

ARGX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 10.0 billion 1.6 billion
March 31, 2026 ? ?
Dec. 31, 2025 8.7 billion 1.4 billion
Sept. 30, 2025 ? ?

ARGX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 748.7 million ?
March 31, 2026 ? ?
Dec. 31, 2025 406.9 million ?
Sept. 30, 2025 ? ?

ARGX Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 838.8 million
March 31, 2026 366.0 million
Dec. 31, 2025 635.7 million
Sept. 30, 2025 344.3 million

ARGX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 5.2 billion - 47.0 million
March 31, 2026 - - -
Dec. 31, 2025 4.4 billion 36.3 million 36.3 million
Sept. 30, 2025 - - -

ARGX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 64.4 million
March 31, 2026 ?
Dec. 31, 2025 66.2 million
Sept. 30, 2025 ?

ARGX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 3.0 million 486.0 million 411.0 million -
March 31, 2026 - 443.0 million 355.0 million -
Dec. 31, 2025 900214 443.0 million 355.0 million -
Sept. 30, 2025 - 355.7 million 336.3 million -

ARGX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 2.8 billion 279.3 million
March 31, 2026 1.3 billion 121.0 million
Dec. 31, 2025 3.2 billion 339.9 million
Sept. 30, 2025 1.1 billion 109.4 million

ARGX

Price: $1,033.15

52 week price:
631.47
1058.90

Earnings Per Share: 26.24 USD

P/E Ratio: 33.24

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: Netherlands

Volume: 205974

Ebitda: -24.6 million

Market Capitalization: 53.8 billion

Links: